Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemic.

Lancet Infect Dis

Eli Lilly and Company, Indianapolis, IN 46285, USA.

Published: November 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512274PMC
http://dx.doi.org/10.1016/S1473-3099(22)00592-8DOI Listing

Publication Analysis

Top Keywords

bebtelovimab considerations
4
considerations global
4
global access
4
access treatments
4
treatments rapidly
4
rapidly evolving
4
evolving pandemic
4
bebtelovimab
1
global
1
access
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!